Press releases
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
Key statistics
On Thursday, Omeros Corp (3O8:FRA) closed at 3.15, 222.21% above the 52 week low of 0.977 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.13 |
---|---|
High | 3.20 |
Low | 3.12 |
Bid | -- |
Offer | -- |
Previous close | 3.13 |
Average volume | 0.00 |
---|---|
Shares outstanding | 62.87m |
Free float | 60.33m |
P/E (TTM) | -- |
Market cap | 215.00m USD |
EPS (TTM) | -2.89 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:55 BST.
More ▼